BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smits SL, de Lang A, van den Brand JM, Leijten LM, van IJcken WF, Eijkemans MJ, van Amerongen G, Kuiken T, Andeweg AC, Osterhaus AD, Haagmans BL. Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog. 2010;6:e1000756. [PMID: 20140198 DOI: 10.1371/journal.ppat.1000756] [Cited by in Crossref: 209] [Cited by in F6Publishing: 205] [Article Influence: 17.4] [Reference Citation Analysis]
Number Citing Articles
1 McGonagle D, O'Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol 2020;2:e437-45. [PMID: 32835247 DOI: 10.1016/S2665-9913(20)30121-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. [PMID: 32171076 DOI: 10.1016/S0140-6736(20)30566-3] [Reference Citation Analysis]
3 Smits SL, van den Brand JM, de Lang A, Leijten LM, van Ijcken WF, van Amerongen G, Osterhaus AD, Andeweg AC, Haagmans BL. Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species. J Virol 2011;85:4234-45. [PMID: 21325418 DOI: 10.1128/JVI.02395-10] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 5.2] [Reference Citation Analysis]
4 Ciabattini A, Garagnani P, Santoro F, Rappuoli R, Franceschi C, Medaglini D. Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population. Semin Immunopathol 2020;42:619-34. [PMID: 33159214 DOI: 10.1007/s00281-020-00821-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
5 [DOI: 10.1101/2020.03.17.995639] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
6 Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, Dekker CL, Didierlaurent AM, Graham BS, Martin SD, Molrine DC, Perlman S, Picard-Fraser PA, Pollard AJ, Qin C, Subbarao K, Cramer JP. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine 2020;38:4783-91. [PMID: 32507409 DOI: 10.1016/j.vaccine.2020.05.064] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 32.5] [Reference Citation Analysis]
7 Rolfo A, Cosma S, Nuzzo AM, Salio C, Moretti L, Sassoè-pognetto M, Carosso AR, Borella F, Cutrin JC, Benedetto C. Increased Placental Anti-Oxidant Response in Asymptomatic and Symptomatic COVID-19 Third-Trimester Pregnancies. Biomedicines 2022;10:634. [DOI: 10.3390/biomedicines10030634] [Reference Citation Analysis]
8 DeDiego ML, Nieto-Torres JL, Jiménez-Guardeño JM, Regla-Nava JA, Alvarez E, Oliveros JC, Zhao J, Fett C, Perlman S, Enjuanes L. Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog 2011;7:e1002315. [PMID: 22028656 DOI: 10.1371/journal.ppat.1002315] [Cited by in Crossref: 122] [Cited by in F6Publishing: 113] [Article Influence: 11.1] [Reference Citation Analysis]
9 Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev 2020;53:33-7. [PMID: 32389499 DOI: 10.1016/j.cytogfr.2020.04.005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 30.5] [Reference Citation Analysis]
10 Arpali E, Akyollu B, Yelken B, Tekin S, Turkmen A, Kocak B. Case report: A kidney transplant patient with mild COVID-19. Transpl Infect Dis 2020;22:e13296. [PMID: 32301198 DOI: 10.1111/tid.13296] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
11 van de Veerdonk FL, Netea MG. Blocking IL-1 to prevent respiratory failure in COVID-19. Crit Care 2020;24:445. [PMID: 32682440 DOI: 10.1186/s13054-020-03166-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
12 Zheng HY, Zhang MX, Chen M, Jiang J, Song JH, Lian XD, Tian RR, Zhang XL, Zhang LT, Pang W, Zhang GH, Zheng YT. Accelerated disease progression and robust innate host response in aged SIVmac239-infected Chinese rhesus macaques is associated with enhanced immunosenescence. Sci Rep 2017;7:37. [PMID: 28232735 DOI: 10.1038/s41598-017-00084-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
13 Majumdar S, Murphy PM. Chemokine Regulation During Epidemic Coronavirus Infection. Front Pharmacol 2020;11:600369. [PMID: 33613280 DOI: 10.3389/fphar.2020.600369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Farne H, Kumar K, Ritchie AI, Finney LJ, Johnston SL, Singanayagam A. Repurposing Existing Drugs for the Treatment of COVID-19. Ann Am Thorac Soc 2020;17:1186-94. [PMID: 32692580 DOI: 10.1513/AnnalsATS.202005-566FR] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
15 Amini N, Mahdavi M, Choubdar H, Abedini A, Shalbaf A, Lashgari R. Automated prediction of COVID-19 mortality outcome using clinical and laboratory data based on hierarchical feature selection and random forest classifier. Comput Methods Biomech Biomed Engin 2022;:1-14. [PMID: 35297747 DOI: 10.1080/10255842.2022.2050906] [Reference Citation Analysis]
16 Chan RW, Chan MC, Agnihothram S, Chan LL, Kuok DI, Fong JH, Guan Y, Poon LL, Baric RS, Nicholls JM, Peiris JS. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol. 2013;87:6604-6614. [PMID: 23552422 DOI: 10.1128/jvi.00009-13] [Cited by in Crossref: 128] [Cited by in F6Publishing: 105] [Article Influence: 14.2] [Reference Citation Analysis]
17 Park A, Iwasaki A. Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19. Cell Host Microbe. 2020;27:870-878. [PMID: 32464097 DOI: 10.1016/j.chom.2020.05.008] [Cited by in Crossref: 289] [Cited by in F6Publishing: 253] [Article Influence: 144.5] [Reference Citation Analysis]
18 Castelli V, Cimini A, Ferri C. Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in". Front Immunol. 2020;11:2132. [PMID: 32983172 DOI: 10.3389/fimmu.2020.02132] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 17.0] [Reference Citation Analysis]
19 Ma X, Guo S, Ruan S, Liu Y, Zang J, Yang Y, Dong H, Li Y, Ren T, An M, Li Y. HACE2-Exosome-Based Nano-Bait for Concurrent SARS-CoV-2 Trapping and Antioxidant Therapy. ACS Appl Mater Interfaces. [DOI: 10.1021/acsami.1c19541] [Reference Citation Analysis]
20 Okba NM, Raj VS, Haagmans BL. Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches. Curr Opin Virol 2017;23:49-58. [PMID: 28412285 DOI: 10.1016/j.coviro.2017.03.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
21 Elizalde González JJ. SARS-CoV-2 y COVID-19. Una revisión de la pandemia. Medicina Crítica 2020;33:53-67. [DOI: 10.35366/93281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
22 Peterson D, Damsky W, King B. Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19. J Am Acad Dermatol 2020;83:e67-8. [PMID: 32344070 DOI: 10.1016/j.jaad.2020.04.097] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
23 Lingappan K, Karmouty-Quintana H, Davies J, Akkanti B, Harting MT. Understanding the age divide in COVID-19: why are children overwhelmingly spared? Am J Physiol Lung Cell Mol Physiol. 2020;319:L39-L44. [PMID: 32491949 DOI: 10.1152/ajplung.00183.2020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 17.5] [Reference Citation Analysis]
24 Peiris J. Coronaviruses. Clinical Virology. Washington: ASM Press; 2016. pp. 1243-65. [DOI: 10.1128/9781555819439.ch52] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Ahmed-Hassan H, Sisson B, Shukla RK, Wijewantha Y, Funderburg NT, Li Z, Hayes D Jr, Demberg T, Liyanage NPM. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections. Front Immunol 2020;11:1979. [PMID: 32973803 DOI: 10.3389/fimmu.2020.01979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Hazeldine J, Lord JM. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19? Front Immunol 2020;11:573662. [PMID: 33123152 DOI: 10.3389/fimmu.2020.573662] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
27 Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, Megawati D, Hayati Z, Wagner AL, Mudatsir M. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health 2020;13:667-73. [PMID: 32340833 DOI: 10.1016/j.jiph.2020.03.019] [Cited by in Crossref: 429] [Cited by in F6Publishing: 302] [Article Influence: 214.5] [Reference Citation Analysis]
28 LoPresti M, Beck DB, Duggal P, Cummings DAT, Solomon BD. The Role of Host Genetic Factors in Coronavirus Susceptibility: Review of Animal and Systematic Review of Human Literature. Am J Hum Genet 2020;107:381-402. [PMID: 32814065 DOI: 10.1016/j.ajhg.2020.08.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 18.5] [Reference Citation Analysis]
29 Mohammad MHS. Immune response scenario and vaccine development for SARS-CoV-2 infection. Int Immunopharmacol 2021;94:107439. [PMID: 33571745 DOI: 10.1016/j.intimp.2021.107439] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
30 Lv XT, Zhu YP, Cheng AG, Jin YX, Ding HB, Wang CY, Zhang SY, Chen GP, Chen QQ, Liu QC. High serum lactate dehydrogenase and dyspnea: Positive predictors of adverse outcome in critical COVID-19 patients in Yichang. World J Clin Cases 2020; 8(22): 5535-5546 [PMID: 33344544 DOI: 10.12998/wjcc.v8.i22.5535] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Shuai W, Chen X, Shan Y, Li W, Ma W, Lu Q, Li D. Clinical Characteristics and CT Findings in 148 Non-COVID-19 Influenza-Like Illness Cases: A Retrospective Control Study. Front Public Health 2021;9:616963. [PMID: 33634067 DOI: 10.3389/fpubh.2021.616963] [Reference Citation Analysis]
32 Homayounieh F, Zhang EW, Babaei R, Karimi Mobin H, Sharifian M, Mohseni I, Kuo A, Arru C, Kalra MK, Digumarthy SR. Clinical and imaging features predict mortality in COVID-19 infection in Iran. PLoS One 2020;15:e0239519. [PMID: 32970733 DOI: 10.1371/journal.pone.0239519] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
33 Gao J, Huang X, Gu H, Lou L, Xu Z. Predictive criteria of severe cases in COVID-19 patients of early stage: A retrospective observational study. J Clin Lab Anal 2020;34:e23562. [PMID: 32893398 DOI: 10.1002/jcla.23562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
34 Feuillet V, Canard B, Trautmann A. Combining Antivirals and Immunomodulators to Fight COVID-19. Trends Immunol 2021;42:31-44. [PMID: 33281063 DOI: 10.1016/j.it.2020.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
35 Alefishat E, Jelinek HF, Mousa M, Tay GK, Alsafar HS. Immune response to SARS-CoV-2 Variants: A focus on severity, susceptibility, and preexisting immunity. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.01.007] [Reference Citation Analysis]
36 Clay CC, Donart N, Fomukong N, Knight JB, Overheim K, Tipper J, Van Westrienen J, Hahn F, Harrod KS. Severe acute respiratory syndrome-coronavirus infection in aged nonhuman primates is associated with modulated pulmonary and systemic immune responses. Immun Ageing 2014;11:4. [PMID: 24642138 DOI: 10.1186/1742-4933-11-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
37 McGruder B, Leibowitz JL. A review of genetic methods and models for analysis of coronavirus-induced severe pneumonitis. J Gen Virol 2015;96:494-506. [PMID: 25252685 DOI: 10.1099/vir.0.069732-0] [Reference Citation Analysis]
38 [DOI: 10.1101/2020.03.30.20047365] [Cited by in Crossref: 238] [Cited by in F6Publishing: 48] [Reference Citation Analysis]
39 Farahani M, Niknam Z, Mohammadi Amirabad L, Amiri-Dashatan N, Koushki M, Nemati M, Danesh Pouya F, Rezaei-Tavirani M, Rasmi Y, Tayebi L. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. Biomed Pharmacother 2022;145:112420. [PMID: 34801852 DOI: 10.1016/j.biopha.2021.112420] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 13.0] [Reference Citation Analysis]
40 Maghzi AH, Houtchens MK, Preziosa P, Ionete C, Beretich BD, Stankiewicz JM, Tauhid S, Cabot A, Berriosmorales I, Schwartz THW, Sloane JA, Freedman MS, Filippi M, Weiner HL, Bakshi R. COVID-19 in teriflunomide-treated patients with multiple sclerosis. J Neurol 2020;267:2790-6. [PMID: 32494856 DOI: 10.1007/s00415-020-09944-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 15.0] [Reference Citation Analysis]
41 Tahaghoghi-Hajghorbani S, Zafari P, Masoumi E, Rajabinejad M, Jafari-Shakib R, Hasani B, Rafiei A. The role of dysregulated immune responses in COVID-19 pathogenesis. Virus Res 2020;290:198197. [PMID: 33069815 DOI: 10.1016/j.virusres.2020.198197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
42 McGonagle D, O'Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020;2:e437-e445. [PMID: 32835247 DOI: 10.1016/s2665-9913(20)30121-1] [Cited by in Crossref: 299] [Cited by in F6Publishing: 189] [Article Influence: 149.5] [Reference Citation Analysis]
43 Mauvais-Jarvis F. Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19. Diabetes 2020;69:1857-63. [PMID: 32669390 DOI: 10.2337/dbi19-0023] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 33.0] [Reference Citation Analysis]
44 Rana AK, Rahmatkar SN, Kumar A, Singh D. Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Cytokine Growth Factor Rev. 2021;58:92-101. [PMID: 32948440 DOI: 10.1016/j.cytogfr.2020.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
45 Wang Z, Wang Z. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak. BMC Infect Dis 2021;21:113. [PMID: 33494706 DOI: 10.1186/s12879-021-05814-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
46 An PJ, Zhu YZ, Yang LP. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications. Pharmacol Res 2020;159:104946. [PMID: 32450346 DOI: 10.1016/j.phrs.2020.104946] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
47 Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
48 Zhu Z, Zheng Z, Liu J. Comparison of COVID-19 and Lung Cancer via Reactive Oxygen Species Signaling. Front Oncol 2021;11:708263. [PMID: 34277453 DOI: 10.3389/fonc.2021.708263] [Reference Citation Analysis]
49 Lemaitre J, Naninck T, Delache B, Creppy J, Huber P, Holzapfel M, Bouillier C, Contreras V, Martinon F, Kahlaoui N, Pascal Q, Tricot S, Ducancel F, Vecellio L, Le Grand R, Maisonnasse P. Non-human primate models of human respiratory infections. Mol Immunol 2021;135:147-64. [PMID: 33895579 DOI: 10.1016/j.molimm.2021.04.010] [Reference Citation Analysis]
50 Körner RW, Majjouti M, Alcazar MAA, Mahabir E. Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2. Viruses 2020;12:E880. [PMID: 32806708 DOI: 10.3390/v12080880] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
51 Han YJ, Lee KH, Yoon S, Nam SW, Ryu S, Seong D, Kim JS, Lee JY, Yang JW, Lee J, Koyanagi A, Hong SH, Dragioti E, Radua J, Smith L, Oh H, Ghayda RA, Kronbichler A, Effenberger M, Kresse D, Denicolò S, Kang W, Jacob L, Shin H, Shin JI. Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials. Theranostics 2021;11:1207-31. [PMID: 33391531 DOI: 10.7150/thno.48342] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
52 Louz D, Bergmans HE, Loos BP, Hoeben RC. Animal models in virus research: their utility and limitations. Crit Rev Microbiol 2013;39:325-61. [PMID: 22978742 DOI: 10.3109/1040841X.2012.711740] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
53 Schneider JL, Rowe JH, Garcia-de-Alba C, Kim CF, Sharpe AH, Haigis MC. The aging lung: Physiology, disease, and immunity. Cell 2021;184:1990-2019. [PMID: 33811810 DOI: 10.1016/j.cell.2021.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
54 van den Brand JM, Smits SL, Haagmans BL. Pathogenesis of Middle East respiratory syndrome coronavirus. J Pathol 2015;235:175-84. [PMID: 25294366 DOI: 10.1002/path.4458] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 12.9] [Reference Citation Analysis]
55 Regla-Nava JA, Nieto-Torres JL, Jimenez-Guardeño JM, Fernandez-Delgado R, Fett C, Castaño-Rodríguez C, Perlman S, Enjuanes L, DeDiego ML. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates. J Virol 2015;89:3870-87. [PMID: 25609816 DOI: 10.1128/JVI.03566-14] [Cited by in Crossref: 74] [Cited by in F6Publishing: 54] [Article Influence: 10.6] [Reference Citation Analysis]
56 Costanzo L, Palumbo FP, Ardita G, Antignani PL, Arosio E, Failla G; Italian Society for Vascular Investigation and the Italian Society of Vascular Medicine. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia. J Vasc Surg Venous Lymphat Disord 2020;8:711-6. [PMID: 32561465 DOI: 10.1016/j.jvsv.2020.05.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
57 Sarker MT, Hasan AQF, Rafi MO, Hossain MJ, El-mageed HRA, Elsapagh RM, Capasso R, Emran TB. A Comprehensive Overview of the Newly Emerged COVID-19 Pandemic: Features, Origin, Genomics, Epidemiology, Treatment, and Prevention. Biologics 2021;1:357-83. [DOI: 10.3390/biologics1030021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Xu HN, Lin Z, Gandhi CK, Amatya S, Wang Y, Li LZ, Floros J. Sex and SP-A2 Dependent NAD(H) Redox Alterations in Mouse Alveolar Macrophages in Response to Ozone Exposure: Potential Implications for COVID-19. Antioxidants (Basel) 2020;9:E915. [PMID: 32992843 DOI: 10.3390/antiox9100915] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
59 Han B, Ma X, Zhang J, Zhang Y, Bai X, Hwang DM, Keshavjee S, Levy GA, McGilvray I, Liu M. Protective effects of long pentraxin PTX3 on lung injury in a severe acute respiratory syndrome model in mice. Lab Invest 2012;92:1285-96. [PMID: 22732935 DOI: 10.1038/labinvest.2012.92] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
60 Vijay R, Hua X, Meyerholz DK, Miki Y, Yamamoto K, Gelb M, Murakami M, Perlman S. Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection. J Exp Med 2015;212:1851-68. [PMID: 26392224 DOI: 10.1084/jem.20150632] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 9.4] [Reference Citation Analysis]
61 Haynes BF, Corey L, Fernandes P, Gilbert PB, Hotez PJ, Rao S, Santos MR, Schuitemaker H, Watson M, Arvin A. Prospects for a safe COVID-19 vaccine. Sci Transl Med 2020;12:eabe0948. [PMID: 33077678 DOI: 10.1126/scitranslmed.abe0948] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 38.5] [Reference Citation Analysis]
62 Willows S, Alam SB, Sandhu JK, Kulka M. A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis. Biochem Cell Biol 2021;99:173-94. [PMID: 33027600 DOI: 10.1139/bcb-2020-0341] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
63 Gralinski LE, Baric RS. Molecular pathology of emerging coronavirus infections. J Pathol 2015;235:185-95. [PMID: 25270030 DOI: 10.1002/path.4454] [Cited by in Crossref: 177] [Cited by in F6Publishing: 175] [Article Influence: 25.3] [Reference Citation Analysis]
64 Vounotrypidis P. COVID-19: An Archetype Innate Immunity Reaction and Modes of Treatment. Mediterr J Rheumatol 2020;31:275-83. [PMID: 33196005 DOI: 10.31138/mjr.31.3.275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Al-Omari A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Bilal M, Alyami SA, Emran TB, Moni MA, Dhama K. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines (Basel) 2021;9:436. [PMID: 33946736 DOI: 10.3390/vaccines9050436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
66 Lin Q, Lu C, Hong Y, Li R, Chen J, Chen W, Chen J. Animal models for studying coronavirus infections and developing antiviral agents and vaccines. Antiviral Research 2022. [DOI: 10.1016/j.antiviral.2022.105345] [Reference Citation Analysis]
67 Orlowski S, Mourad JJ, Gallo A, Bruckert E. Coronaviruses, cholesterol and statins: Involvement and application for Covid-19. Biochimie 2021;189:51-64. [PMID: 34153377 DOI: 10.1016/j.biochi.2021.06.005] [Reference Citation Analysis]
68 Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 2022. [PMID: 35354968 DOI: 10.1038/s41579-022-00713-0] [Reference Citation Analysis]
69 Freeman TL, Swartz TH. Targeting the NLRP3 Inflammasome in Severe COVID-19. Front Immunol 2020;11:1518. [PMID: 32655582 DOI: 10.3389/fimmu.2020.01518] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 49.5] [Reference Citation Analysis]
70 Tao K, Tzou PL, Nouhin J, Bonilla H, Jagannathan P, Shafer RW. SARS-CoV-2 Antiviral Therapy. Clin Microbiol Rev 2021;:e0010921. [PMID: 34319150 DOI: 10.1128/CMR.00109-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Sehrawat S, Rouse BT. COVID-19: disease, or no disease? - that is the question. It's the dose stupid! Microbes Infect 2021;23:104779. [PMID: 33450356 DOI: 10.1016/j.micinf.2021.104779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Morales L, Oliveros JC, Enjuanes L, Sola I. Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology. mBio 2022;:e0313521. [PMID: 35229638 DOI: 10.1128/mbio.03135-21] [Reference Citation Analysis]
73 Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 11.5] [Reference Citation Analysis]
74 Zhang C, Tu Y, Sun X, Chen D, Zhang W, Zhuang C, Wang Z, Su L. Peramivir, an Anti-Influenza Virus Drug, Exhibits Potential Anti-Cytokine Storm Effects. Front Immunol 2022;13:856327. [DOI: 10.3389/fimmu.2022.856327] [Reference Citation Analysis]
75 Simbirtsev AS. Immunopathogenesis and perspectives for immunotherapy of coronavirus infection. VIČ-infekc immunosupr 2021;12:7-22. [DOI: 10.22328/2077-9828-2020-12-4-7-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 2020;395:1054-62. [DOI: 10.1016/s0140-6736(20)30566-3] [Reference Citation Analysis]
77 Jutzeler CR, Bourguignon L, Weis CV, Tong B, Wong C, Rieck B, Pargger H, Tschudin-Sutter S, Egli A, Borgwardt K, Walter M. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020;37:101825. [PMID: 32763496 DOI: 10.1016/j.tmaid.2020.101825] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 23.5] [Reference Citation Analysis]
78 de Wit E, Rasmussen AL, Falzarano D, Bushmaker T, Feldmann F, Brining DL, Fischer ER, Martellaro C, Okumura A, Chang J, Scott D, Benecke AG, Katze MG, Feldmann H, Munster VJ. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A 2013;110:16598-603. [PMID: 24062443 DOI: 10.1073/pnas.1310744110] [Cited by in Crossref: 206] [Cited by in F6Publishing: 198] [Article Influence: 22.9] [Reference Citation Analysis]
79 Schönrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Adv Biol Regul 2020;77:100741. [PMID: 32773102 DOI: 10.1016/j.jbior.2020.100741] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 31.5] [Reference Citation Analysis]
80 Nelemans T, Kikkert M. Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections. Viruses 2019;11:E961. [PMID: 31635238 DOI: 10.3390/v11100961] [Cited by in Crossref: 87] [Cited by in F6Publishing: 76] [Article Influence: 29.0] [Reference Citation Analysis]
81 Qian Z, Travanty EA, Oko L, Edeen K, Berglund A, Wang J, Ito Y, Holmes KV, Mason RJ. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol. 2013;48:742-748. [PMID: 23418343 DOI: 10.1165/rcmb.2012-0339oc] [Cited by in Crossref: 170] [Cited by in F6Publishing: 113] [Article Influence: 18.9] [Reference Citation Analysis]
82 DeDiego ML, Nieto-Torres JL, Jimenez-Guardeño JM, Regla-Nava JA, Castaño-Rodriguez C, Fernandez-Delgado R, Usera F, Enjuanes L. Coronavirus virulence genes with main focus on SARS-CoV envelope gene. Virus Res 2014;194:124-37. [PMID: 25093995 DOI: 10.1016/j.virusres.2014.07.024] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 11.0] [Reference Citation Analysis]
83 Totura AL, Baric RS. SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr Opin Virol 2012;2:264-75. [PMID: 22572391 DOI: 10.1016/j.coviro.2012.04.004] [Cited by in Crossref: 257] [Cited by in F6Publishing: 238] [Article Influence: 25.7] [Reference Citation Analysis]
84 Wang F, Hou H, Wang T, Luo Y, Tang G, Wu S, Zhou H, Sun Z. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests. Travel Med Infect Dis 2020;36:101782. [PMID: 32526372 DOI: 10.1016/j.tmaid.2020.101782] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
85 Pagliari F, Marafioti MG, Genard G, Candeloro P, Viglietto G, Seco J, Tirinato L. ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection? Front Mol Biosci 2020;7:578964. [PMID: 33134318 DOI: 10.3389/fmolb.2020.578964] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
86 Bolevich SB, Litvitsky PF, Grachev SV, Vorobyev SI, Orlova AS, Fokina MA, Novikov AA, Bolevich SS, Mikhaleva AY, Morozova EM, Kartashova MK, Yavlieva KH, Gudanovich DV, Srejovic I, Jakovljevic V. Fundamental Basis of COVID-19 Pathogenesis. Serbian Journal of Experimental and Clinical Research 2020;21:93-111. [DOI: 10.2478/sjecr-2020-0029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
87 Zheng Y, Li S, Song K, Ye J, Li W, Zhong Y, Feng Z, Liang S, Cai Z, Xu K. A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses. Viruses 2022;14:928. [DOI: 10.3390/v14050928] [Reference Citation Analysis]
88 Bepouka BI, Mandina M, Makulo JR, Longokolo M, Odio O, Mayasi N, Pata T, Nsangana G, Tshikangu F, Mangala D, Maheshe D, Nkarnkwin S, Muamba J, Ndaie G, Ngwizani R, Yanga Y, Nkodila A, Keke H, Kokusa Y, Lepira F, Kashongwe I, Mbula M, Kayembe JM, Situakibanza H. Predictors of mortality in COVID-19 patients at Kinshasa University Hospital, Democratic Republic of the Congo, from March to June 2020. Pan Afr Med J 2020;37:105. [PMID: 33425138 DOI: 10.11604/pamj.2020.37.105.25279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
89 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 2020;395:1054-62. [DOI: 10.1016/s0140-6736(20)30566-3] [Reference Citation Analysis]
90 Canton J, Fehr AR, Fernandez-Delgado R, Gutierrez-Alvarez FJ, Sanchez-Aparicio MT, García-Sastre A, Perlman S, Enjuanes L, Sola I. MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection. PLoS Pathog 2018;14:e1006838. [PMID: 29370303 DOI: 10.1371/journal.ppat.1006838] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 17.3] [Reference Citation Analysis]
91 Chua KH, Mohamed IN, Mohd Yunus MH, Shafinaz Md Nor N, Kamil K, Ugusman A, Kumar J. The Anti-Viral and Anti-Inflammatory Properties of Edible Bird's Nest in Influenza and Coronavirus Infections: From Pre-Clinical to Potential Clinical Application. Front Pharmacol 2021;12:633292. [PMID: 34025406 DOI: 10.3389/fphar.2021.633292] [Reference Citation Analysis]
92 Clementi N, Ferrarese R, Criscuolo E, Diotti RA, Castelli M, Scagnolari C, Burioni R, Antonelli G, Clementi M, Mancini N. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection. J Infect Dis 2020;222:722-5. [PMID: 32559285 DOI: 10.1093/infdis/jiaa350] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 18.0] [Reference Citation Analysis]
93 Widagdo W, Okba NMA, Stalin Raj V, Haagmans BL. MERS-coronavirus: From discovery to intervention. One Health 2017;3:11-6. [PMID: 28616497 DOI: 10.1016/j.onehlt.2016.12.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
94 Kumaki Y, Ennis J, Rahbar R, Turner JD, Wandersee MK, Smith AJ, Bailey KW, Vest ZG, Madsen JR, Li JK, Barnard DL. Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model. Antiviral Res 2011;89:75-82. [PMID: 21093489 DOI: 10.1016/j.antiviral.2010.11.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
95 Strayer DR, Carter WA, Stouch BC, Stittelaar KJ, Thoolen RJ, Osterhaus AD, Mitchell WM. Protection from pulmonary tissue damage associated with infection of cynomolgus macaques by highly pathogenic avian influenza virus (H5N1) by low dose natural human IFN-α administered to the buccal mucosa. Antiviral Res 2014;110:175-80. [PMID: 25111905 DOI: 10.1016/j.antiviral.2014.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
96 Li S, Yang F, Ma C, Cao W, Yang J, Zhao Z, Tian H, Zhu Z, Zheng H. Porcine epidemic diarrhea virus nsp14 inhibits NF-κB pathway activation by targeting the IKK complex and p65. Anim Dis 2021;1:24. [PMID: 34778885 DOI: 10.1186/s44149-021-00025-5] [Reference Citation Analysis]
97 Muhammad R, Ogunti R, Ahmed B, Munawar M, Donaldson S, Sumon M, Kibreab A, Thomas AN, Mehari A. Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection. J Racial Ethn Health Disparities 2021. [PMID: 33538998 DOI: 10.1007/s40615-020-00961-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Mullick JB, Simmons CS, Gaire J. Animal Models to Study Emerging Technologies Against SARS-CoV-2. Cell Mol Bioeng 2020;:1-11. [PMID: 32837584 DOI: 10.1007/s12195-020-00638-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
99 Sarapultsev A, Sarapultsev P. Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID-19 patients. Am J Reprod Immunol 2020;84:e13285. [PMID: 32516444 DOI: 10.1111/aji.13285] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
100 Torres J, Surya W, Li Y, Liu DX. Protein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals? Viruses 2015;7:2858-83. [PMID: 26053927 DOI: 10.3390/v7062750] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
101 Albini A, Calabrone L, Carlini V, Benedetto N, Lombardo M, Bruno A, Noonan DM. Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis. Front Immunol 2021;12:718136. [PMID: 34646263 DOI: 10.3389/fimmu.2021.718136] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Harford JB, Kim SS, Pirollo KF, Chang EH. TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19. Viruses 2022;14:739. [DOI: 10.3390/v14040739] [Reference Citation Analysis]
103 Khalil BA, Shakartalla SB, Goel S, Madkhana B, Halwani R, Maghazachi AA, Alsafar H, Al-omari B, Al Bataineh MT. Immune Profiling of COVID-19 in Correlation with SARS and MERS. Viruses 2022;14:164. [DOI: 10.3390/v14010164] [Reference Citation Analysis]
104 Storci G, Bonifazi F, Garagnani P, Olivieri F, Bonafè M. The role of extracellular DNA in COVID-19: Clues from inflamm-aging. Ageing Res Rev 2021;66:101234. [PMID: 33321254 DOI: 10.1016/j.arr.2020.101234] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
105 Osterhaus AD, Smits SL. Emerging Viral Infections. Genomic and Personalized Medicine. Elsevier; 2013. pp. 1142-54. [DOI: 10.1016/b978-0-12-382227-7.00097-5] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
106 Keum YS, Jeong YJ. Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target. Biochem Pharmacol 2012;84:1351-8. [PMID: 22935448 DOI: 10.1016/j.bcp.2012.08.012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
107 Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, Sun R, Tian Z, Xu X, Wei H. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. National Science Review 2020;7:998-1002. [DOI: 10.1093/nsr/nwaa041] [Cited by in Crossref: 407] [Cited by in F6Publishing: 114] [Article Influence: 203.5] [Reference Citation Analysis]
108 Hayashi T, Chaichoune K, Patchimasiri T, Hiromoto Y, Kawasaki Y, Wiriyarat W, Chakritbudsabong W, Prayoonwong N, Chaisilp N, Parchariyanon S, Ratanakorn P, Uchida Y, Tsuda T, Saito T. Differential host gene responses in mice infected with two highly pathogenic avian influenza viruses of subtype H5N1 isolated from wild birds in Thailand. Virology 2011;412:9-18. [PMID: 21251691 DOI: 10.1016/j.virol.2010.12.040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
109 Singh D, Wasan H, Reeta KH. Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications. Free Radic Biol Med 2020;161:263-71. [PMID: 33091573 DOI: 10.1016/j.freeradbiomed.2020.10.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
110 Gustafson D, Raju S, Wu R, Ching C, Veitch S, Rathnakumar K, Boudreau E, Howe KL, Fish JE. Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis? Arterioscler Thromb Vasc Biol 2020;40:1818-29. [PMID: 32510978 DOI: 10.1161/ATVBAHA.120.314558] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 16.5] [Reference Citation Analysis]
111 To J, Surya W, Torres J. Targeting the Channel Activity of Viroporins. Adv Protein Chem Struct Biol 2016;104:307-55. [PMID: 27038378 DOI: 10.1016/bs.apcsb.2015.12.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
112 Zhao J, Wohlford-Lenane C, Zhao J, Fleming E, Lane TE, McCray PB, Perlman S. Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections. J Virol. 2012;86:11416-11424. [PMID: 22915814 DOI: 10.1128/jvi.01410-12] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 7.2] [Reference Citation Analysis]
113 Lu L, Zhong W, Bian Z, Li Z, Zhang K, Liang B, Zhong Y, Hu M, Lin L, Liu J, Lin X, Huang Y, Jiang J, Yang X, Zhang X, Huang Z. A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis. J Infect 2020;81:e18-25. [PMID: 32634459 DOI: 10.1016/j.jinf.2020.07.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 23.5] [Reference Citation Analysis]
114 Zhang J, Zhao C, Zhao W. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19. Front Immunol 2021;12:633769. [PMID: 33912161 DOI: 10.3389/fimmu.2021.633769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Gautam A, Kaphle K, Shrestha B, Phuyal S. Susceptibility to SARS, MERS, and COVID-19 from animal health perspective. Open Vet J 2020;10:164-77. [PMID: 32821661 DOI: 10.4314/ovj.v10i2.6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
116 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 2020;395:1054-62. [DOI: 10.1016/s0140-6736(20)30566-3] [Reference Citation Analysis]
117 Josset L, Engelmann F, Haberthur K, Kelly S, Park B, Kawoaka Y, García-Sastre A, Katze MG, Messaoudi I. Increased viral loads and exacerbated innate host responses in aged macaques infected with the 2009 pandemic H1N1 influenza A virus. J Virol 2012;86:11115-27. [PMID: 22855494 DOI: 10.1128/JVI.01571-12] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
118 Agarwal MA, Ziaeian B, Lavie CJ, Fonarow GC. Cardiovascular Disease in Hospitalized Patients With a Diagnosis of Coronavirus From the Pre-COVID-19 Era in United States: National Analysis From 2016-2017. Mayo Clin Proc 2020;95:2674-83. [PMID: 33276839 DOI: 10.1016/j.mayocp.2020.09.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
119 Kumar R, Lee MH, Mickael C, Kassa B, Pasha Q, Tuder R, Graham B. Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19. ERJ Open Res 2020;6:00405-2020. [PMID: 33313306 DOI: 10.1183/23120541.00405-2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
120 Schijns V, Lavelle EC. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity. Eur J Immunol 2020;50:932-8. [PMID: 32438473 DOI: 10.1002/eji.202048693] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 17.0] [Reference Citation Analysis]
121 Zhang R, Wang X, Ni L, Di X, Ma B, Niu S, Liu C, Reiter RJ. COVID-19: Melatonin as a potential adjuvant treatment. Life Sci 2020;250:117583. [PMID: 32217117 DOI: 10.1016/j.lfs.2020.117583] [Cited by in Crossref: 235] [Cited by in F6Publishing: 215] [Article Influence: 117.5] [Reference Citation Analysis]
122 Chen J, Kelley WJ, Goldstein DR. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19. J Immunol 2020;205:313-20. [PMID: 32493812 DOI: 10.4049/jimmunol.2000380] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
123 Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, Wei J, Gong Z, Zhou C, Yu H, Yu M, Lei H, Cheng F, Zhang B, Xu Y, Wang G, Dong W. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect 2020;26:767-72. [PMID: 32304745 DOI: 10.1016/j.cmi.2020.04.012] [Cited by in Crossref: 245] [Cited by in F6Publishing: 240] [Article Influence: 122.5] [Reference Citation Analysis]
124 Song P, Li W, Xie J, Hou Y, You C. Cytokine storm induced by SARS-CoV-2. Clin Chim Acta 2020;509:280-7. [PMID: 32531256 DOI: 10.1016/j.cca.2020.06.017] [Cited by in Crossref: 174] [Cited by in F6Publishing: 155] [Article Influence: 87.0] [Reference Citation Analysis]
125 Jha N, Jeyaraman M, Rachamalla M, Ojha S, Dua K, Chellappan D, Muthu S, Sharma A, Jha S, Jain R, Jeyaraman N, Gs P, Satyam R, Khan F, Pandey P, Verma N, Singh S, Roychoudhury S, Dholpuria S, Ruokolainen J, Kesari K. Current Understanding of Novel Coronavirus: Molecular Pathogenesis, Diagnosis, and Treatment Approaches. Immuno 2021;1:30-66. [DOI: 10.3390/immuno1010004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
126 [DOI: 10.1101/2020.03.25.008482] [Cited by in Crossref: 47] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
127 Lupu L, Palmer A, Huber-Lang M. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS. Front Immunol. 2020;11:584514. [PMID: 33101314 DOI: 10.3389/fimmu.2020.584514] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
128 Hayden FG. Advances in antivirals for non-influenza respiratory virus infections. Influenza Other Respir Viruses 2013;7 Suppl 3:36-43. [PMID: 24215380 DOI: 10.1111/irv.12173] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
129 Li M, Cheng B, Zeng W, Chen S, Tu M, Wu M, Tong W, Wang S, Huang Y, Long W, Zhou W, Chen D, Zhou L, Wang M, Xu H, Deng A, Liu Z, Guo L. Analysis of the Risk Factors for Mortality in Adult COVID-19 Patients in Wuhan: A Multicenter Study. Front Med (Lausanne) 2020;7:545. [PMID: 32984387 DOI: 10.3389/fmed.2020.00545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
130 DeDiego ML, Nieto-Torres JL, Regla-Nava JA, Jimenez-Guardeño JM, Fernandez-Delgado R, Fett C, Castaño-Rodriguez C, Perlman S, Enjuanes L. Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J Virol 2014;88:913-24. [PMID: 24198408 DOI: 10.1128/JVI.02576-13] [Cited by in Crossref: 210] [Cited by in F6Publishing: 172] [Article Influence: 23.3] [Reference Citation Analysis]
131 Hou W, Zhang W, Jin R, Liang L, Xu B, Hu Z. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study. Infect Dis (Lond) 2020;52:498-505. [PMID: 32370577 DOI: 10.1080/23744235.2020.1759817] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 30.0] [Reference Citation Analysis]
132 Keles ES. Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities. New Microbes New Infect 2020;36:100723. [PMID: 32670592 DOI: 10.1016/j.nmni.2020.100723] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
133 Karst M, Hollenhorst J, Achenbach J. Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia? Med Hypotheses 2020;144:110234. [PMID: 33254541 DOI: 10.1016/j.mehy.2020.110234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
134 Xu D, Xu X, Fan Z, Zou M, Qin X, Ding Y, Peng Y, Zhang K. Hypersensitive detection of transcription factors by multiple amplification strategy based on molecular beacon. Microchemical Journal 2021;171:106837. [DOI: 10.1016/j.microc.2021.106837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Jimenez-Guardeño JM, Regla-Nava JA, Nieto-Torres JL, DeDiego ML, Castaño-Rodriguez C, Fernandez-Delgado R, Perlman S, Enjuanes L. Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine. PLoS Pathog 2015;11:e1005215. [PMID: 26513244 DOI: 10.1371/journal.ppat.1005215] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 12.1] [Reference Citation Analysis]
136 Abdin SM, Elgendy SM, Alyammahi SK, Alhamad DW, Omar HA. Tackling the cytokine storm in COVID-19, challenges and hopes. Life Sci 2020;257:118054. [PMID: 32663575 DOI: 10.1016/j.lfs.2020.118054] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
137 Yu C, Lei Q, Li W, Wang X, Liu W, Fan X, Li W. Clinical Characteristics, Associated Factors, and Predicting COVID-19 Mortality Risk: A Retrospective Study in Wuhan, China. Am J Prev Med 2020;59:168-75. [PMID: 32564974 DOI: 10.1016/j.amepre.2020.05.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 24.5] [Reference Citation Analysis]
138 Delgado-Roche L, Mesta F. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection. Arch Med Res. 2020;51:384-387. [PMID: 32402576 DOI: 10.1016/j.arcmed.2020.04.019] [Cited by in Crossref: 159] [Cited by in F6Publishing: 150] [Article Influence: 79.5] [Reference Citation Analysis]
139 Attiq A, Yao LJ, Afzal S, Khan MA. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19. Int Immunopharmacol 2021;101:108255. [PMID: 34688149 DOI: 10.1016/j.intimp.2021.108255] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
140 Vijay R, Perlman S. Middle East respiratory syndrome and severe acute respiratory syndrome. Curr Opin Virol 2016;16:70-6. [PMID: 26855039 DOI: 10.1016/j.coviro.2016.01.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
141 Quarleri J, Delpino MV. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors. Cytokine Growth Factor Rev 2021;58:55-65. [PMID: 33608189 DOI: 10.1016/j.cytogfr.2021.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
142 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. [PMID: 32171076 DOI: 10.1016/S0140-6736(20)30566-3] [Reference Citation Analysis]
143 Kadkhoda K. COVID-19: an Immunopathological View. mSphere 2020;5:e00344-20. [PMID: 32321823 DOI: 10.1128/mSphere.00344-20] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 19.0] [Reference Citation Analysis]
144 Weston S, Coleman CM, Haupt R, Logue J, Matthews K, Li Y, Reyes HM, Weiss SR, Frieman MB. Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo. J Virol 2020;94:e01218-20. [PMID: 32817221 DOI: 10.1128/JVI.01218-20] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 32.5] [Reference Citation Analysis]
145 Smits SL, Osterhaus AD. Virus discovery: one step beyond. Curr Opin Virol 2013;3:e1-6. [PMID: 23578938 DOI: 10.1016/j.coviro.2013.03.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
146 Sanclemente-Alaman I, Moreno-Jiménez L, Benito-Martín MS, Canales-Aguirre A, Matías-Guiu JA, Matías-Guiu J, Gómez-Pinedo U. Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2. Front Immunol 2020;11:2163. [PMID: 32983181 DOI: 10.3389/fimmu.2020.02163] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
147 Hu XS, Hu CH, Zhong P, Wen YJ, Chen XY. Risk factors associated with acute respiratory distress syndrome in COVID-19 patients outside Wuhan: A double-center retrospective cohort study of 197 cases in Hunan, China. World J Clin Cases 2021; 9(2): 344-356 [PMID: 33521102 DOI: 10.12998/wjcc.v9.i2.344] [Reference Citation Analysis]
148 Paces J, Strizova Z, Smrz D, Cerny J. COVID-19 and the immune system. Physiol Res 2020;69:379-88. [PMID: 32469225 DOI: 10.33549/physiolres.934492] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 34.5] [Reference Citation Analysis]
149 Li Y, Li J, Ke J, Jiao N, Zhu L, Shen L, Chen L, Jiang Z, Cheng S, Huang Y, Zou Y, Zhu R, Yan G. Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study. Front Med (Lausanne) 2021;8:604263. [PMID: 33634148 DOI: 10.3389/fmed.2021.604263] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Sims AC, Tilton SC, Menachery VD, Gralinski LE, Schäfer A, Matzke MM, Webb-Robertson BJ, Chang J, Luna ML, Long CE. Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells. J Virol. 2013;87:3885-3902. [PMID: 23365422 DOI: 10.1128/jvi.02520-12] [Cited by in Crossref: 91] [Cited by in F6Publishing: 64] [Article Influence: 10.1] [Reference Citation Analysis]
151 Sheahan T, Whitmore A, Long K, Ferris M, Rockx B, Funkhouser W, Donaldson E, Gralinski L, Collier M, Heise M, Davis N, Johnston R, Baric RS. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus. J Virol 2011;85:217-30. [PMID: 20980507 DOI: 10.1128/JVI.01805-10] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
152 Li T, Lu L, Zhang W, Tao Y, Wang L, Bao J, Liu B, Duan J. Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China. Arch Gerontol Geriatr 2020;91:104185. [PMID: 32688107 DOI: 10.1016/j.archger.2020.104185] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
153 Stalin Raj V, Okba NMA, Gutierrez-Alvarez J, Drabek D, van Dieren B, Widagdo W, Lamers MM, Widjaja I, Fernandez-Delgado R, Sola I, Bensaid A, Koopmans MP, Segalés J, Osterhaus ADME, Bosch BJ, Enjuanes L, Haagmans BL. Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection. Sci Adv 2018;4:eaas9667. [PMID: 30101189 DOI: 10.1126/sciadv.aas9667] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 11.8] [Reference Citation Analysis]
154 Genebat M, Tarancón-Díez L, de Pablo-Bernal R, Calderón A, Muñoz-Fernández MÁ, Leal M. Coronavirus Disease (COVID-19): A Perspective from Immunosenescence. Aging Dis 2021;12:3-6. [PMID: 33532121 DOI: 10.14336/AD.2020.0831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Monji F, Al-Mahmood Siddiquee A, Hashemian F. Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic. Eur J Pharmacol 2020;887:173561. [PMID: 32946870 DOI: 10.1016/j.ejphar.2020.173561] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
156 Midha IK, Kumar N, Kumar A, Madan T. Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings. Rev Med Virol 2021;31:1-14. [PMID: 33382930 DOI: 10.1002/rmv.2204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
157 Zhou H, Fang Y, Xu T, Ni WJ, Shen AZ, Meng XM. Potential therapeutic targets and promising drugs for combating SARS-CoV-2. Br J Pharmacol 2020;177:3147-61. [PMID: 32368792 DOI: 10.1111/bph.15092] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 16.5] [Reference Citation Analysis]
158 Neil JA, Griffith M, Godfrey DI, Purcell DFJ, Deliyannis G, Jackson D, Rockman S, Subbarao K, Nolan T. Nonhuman primate models for evaluation of SARS-CoV-2 vaccines. Expert Rev Vaccines 2022;:1-16. [PMID: 35652289 DOI: 10.1080/14760584.2022.2071264] [Reference Citation Analysis]
159 Wu F, Liu M, Wang A, Lu L, Wang Q, Gu C, Chen J, Wu Y, Xia S, Ling Y, Zhang Y, Xun J, Zhang R, Xie Y, Jiang S, Zhu T, Lu H, Wen Y, Huang J. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China. JAMA Intern Med 2020;180:1356-62. [PMID: 32808970 DOI: 10.1001/jamainternmed.2020.4616] [Cited by in Crossref: 107] [Cited by in F6Publishing: 100] [Article Influence: 53.5] [Reference Citation Analysis]
160 Maveddat A, Mallah H, Rao S, Ali K, Sherali S, Nugent K. Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2). Int J Occup Environ Med 2020;11:157-78. [PMID: 33098401 DOI: 10.34172/ijoem.2020.2202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
161 Kleszczyński K, Slominski AT, Steinbrink K, Reiter RJ. Clinical Trials for Use of Melatonin to Fight against COVID-19 Are Urgently Needed. Nutrients 2020;12:E2561. [PMID: 32847033 DOI: 10.3390/nu12092561] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
162 Falcone C, Caracciolo M, Correale P, Macheda S, Vadalà EG, La Scala S, Tescione M, Danieli R, Ferrarelli A, Tarsitano MG, Romano L, De Lorenzo A. Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome? J Clin Med 2020;9:E3045. [PMID: 32967358 DOI: 10.3390/jcm9093045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
163 Wachtman L, Mansfield K. Viral Diseases of Nonhuman Primates. Nonhuman Primates in Biomedical Research. Elsevier; 2012. pp. 1-104. [DOI: 10.1016/b978-0-12-381366-4.00001-8] [Cited by in Crossref: 7] [Article Influence: 0.7] [Reference Citation Analysis]
164 Zhao M, Wang M, Zhang J, Gu J, Zhang P, Xu Y, Ye J, Wang Z, Ye D, Pan W, Shen B, He H, Liu M, Liu M, Luo Z, Li D, Liu J, Wan J. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages. Aging (Albany NY) 2020;12:10070-86. [PMID: 32499448 DOI: 10.18632/aging.103298] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
165 Regla-Nava JA, Jimenez-Guardeño JM, Nieto-Torres JL, Gallagher TM, Enjuanes L, DeDiego ML. The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokines. J Virol Methods 2013;193:639-46. [PMID: 23911968 DOI: 10.1016/j.jviromet.2013.07.039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
166 Naaraayan A, Nimkar A, Hasan A, Pant S, Durdevic M, Elenius H, Nava Suarez C, Jesmajian S. Analysis of Male Sex as a Risk Factor in Older Adults With Coronavirus Disease 2019: A Retrospective Cohort Study From the New York City Metropolitan Region. Cureus. 2020;12:e9912. [PMID: 32974111 DOI: 10.7759/cureus.9912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
167 Ma Q, Wang Z, Chen R, Lei B, Liu B, Jiang H, Chen Z, Cai X, Guo X, Zhou M, Huang J, Li X, Dai J, Yang Z. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action. Phytomedicine 2021;95:153874. [PMID: 34923232 DOI: 10.1016/j.phymed.2021.153874] [Reference Citation Analysis]
168 Jimenez-Guardeño JM, Nieto-Torres JL, DeDiego ML, Regla-Nava JA, Fernandez-Delgado R, Castaño-Rodriguez C, Enjuanes L. The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis. PLoS Pathog 2014;10:e1004320. [PMID: 25122212 DOI: 10.1371/journal.ppat.1004320] [Cited by in Crossref: 116] [Cited by in F6Publishing: 107] [Article Influence: 14.5] [Reference Citation Analysis]
169 Yin J, Li C, Ye C, Ruan Z, Liang Y, Li Y, Wu J, Luo Z. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.01.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
170 Lara PC, Macías-Verde D, Burgos-Burgos J. Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients. Aging Dis 2020;11:756-62. [PMID: 32765942 DOI: 10.14336/AD.2020.0601] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
171 Kircheis R, Haasbach E, Lueftenegger D, Heyken WT, Ocker M, Planz O. NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients. Front Immunol 2020;11:598444. [PMID: 33362782 DOI: 10.3389/fimmu.2020.598444] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 12.5] [Reference Citation Analysis]
172 Khamis F, Memish Z, Bahrani MA, Dowaiki SA, Pandak N, Bolushi ZA, Salmi IA, Al-Zakwani I. Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection. J Infect Public Health 2021;14:759-65. [PMID: 34022734 DOI: 10.1016/j.jiph.2021.03.016] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
173 Barnard DL, Kumaki Y. Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy. Future Virol 2011;6:615-31. [PMID: 21765859 DOI: 10.2217/fvl.11.33] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
174 Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529-539. [PMID: 28466096 DOI: 10.1007/s00281-017-0629-x] [Cited by in Crossref: 1170] [Cited by in F6Publishing: 1094] [Article Influence: 234.0] [Reference Citation Analysis]
175 Tascioglu D, Akkaya E, Genc S. The understanding of the immunopathology in COVID-19 infection. Scand J Clin Lab Invest 2021;81:255-63. [PMID: 34032527 DOI: 10.1080/00365513.2021.1892817] [Reference Citation Analysis]
176 Kocak B, Arpali E, Akyollu B, Yelken B, Tekin S, Kanbay M, Turkmen A, Kalayoglu M. Oligosymptomatic Kidney Transplant Patients With COVID-19: Do They Pose a Risk to Other Recipients? Transplant Proc 2020;52:2663-6. [PMID: 32419709 DOI: 10.1016/j.transproceed.2020.05.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
177 Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. J Infect. 2020;80:607-613. [PMID: 32283152 DOI: 10.1016/j.jinf.2020.03.037] [Cited by in Crossref: 1000] [Cited by in F6Publishing: 975] [Article Influence: 500.0] [Reference Citation Analysis]
178 Kabeerdoss J, Danda D. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists? Int J Rheum Dis 2020;23:998-1008. [PMID: 32779341 DOI: 10.1111/1756-185X.13909] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
179 Bhargava A, Fukushima EA, Levine M, Zhao W, Tanveer F, Szpunar SM, Saravolatz L. Predictors for Severe COVID-19 Infection. Clin Infect Dis 2020;71:1962-8. [PMID: 32472676 DOI: 10.1093/cid/ciaa674] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 31.5] [Reference Citation Analysis]
180 Rivera A, Rais M, Barr T, Arnold N, Sureshchandra S, Messaoudi I. Nonhuman Primate Models of Immunosenescence. In: Fulop T, Franceschi C, Hirokawa K, Pawelec G, editors. Handbook of Immunosenescence. Cham: Springer International Publishing; 2017. pp. 1-28. [DOI: 10.1007/978-3-319-64597-1_80-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
181 Smirnov VS, Totolian AA. Some opportunities for immunotherapy in coronavirus infection. Russian Journal of Infection and Immunity 2020;10:446-58. [DOI: 10.15789/2220-7619-spo-1470] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
182 Hu D, Lou X, Meng N, Li Z, Teng Y, Zou Y, Wang F. Influence of age and gender on the epidemic of COVID-19 : Evidence from 177 countries and territories-an exploratory, ecological study. Wien Klin Wochenschr 2021;133:321-30. [PMID: 33547492 DOI: 10.1007/s00508-021-01816-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
183 Hu X, Hu C, Yang Y, Chen J, Zhong P, Wen Y, Chen X. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China. Ther Adv Respir Dis 2020;14:1753466620963035. [PMID: 33138694 DOI: 10.1177/1753466620963035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
184 Vlasova AN, Saif LJ. BIOLOGICAL ASPECTS OF THE INTERSPECIES TRANSMISSION OF SELECTED CORONAVIRUSES. In: Singh SK, editor. Viral Infections and Global Change. Hoboken: John Wiley & Sons, Inc; 2013. pp. 393-418. [DOI: 10.1002/9781118297469.ch21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
185 Bouayad A. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.Rev Med Virol. 2020;30:1-9. [PMID: 32734714 DOI: 10.1002/rmv.2135] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
186 Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell 2021;184:1671-92. [PMID: 33743212 DOI: 10.1016/j.cell.2021.02.029] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 49.0] [Reference Citation Analysis]
187 Graham RL, Becker MM, Eckerle LD, Bolles M, Denison MR, Baric RS. A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nat Med 2012;18:1820-6. [PMID: 23142821 DOI: 10.1038/nm.2972] [Cited by in Crossref: 160] [Cited by in F6Publishing: 140] [Article Influence: 16.0] [Reference Citation Analysis]
188 Song TZ, Zheng HY, Han JB, Jin L, Yang X, Liu FL, Luo RH, Tian RR, Cai HR, Feng XL, Liu C, Li MH, Zheng YT. Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques. Zool Res 2020;41:503-16. [PMID: 32772513 DOI: 10.24272/j.issn.2095-8137.2020.202] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
189 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062. [PMID: 32171076 DOI: 10.1016/s0140-6736(20)30566-3] [Cited by in Crossref: 11538] [Cited by in F6Publishing: 7554] [Article Influence: 5769.0] [Reference Citation Analysis]
190 Rockx B, Feldmann F, Brining D, Gardner D, LaCasse R, Kercher L, Long D, Rosenke R, Virtaneva K, Sturdevant DE, Porcella SF, Mattoon J, Parnell M, Baric RS, Feldmann H. Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaques. PLoS One 2011;6:e18558. [PMID: 21533129 DOI: 10.1371/journal.pone.0018558] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
191 Johansen MD, Irving A, Montagutelli X, Tate MD, Rudloff I, Nold MF, Hansbro NG, Kim RY, Donovan C, Liu G, Faiz A, Short KR, Lyons JG, McCaughan GW, Gorrell MD, Cole A, Moreno C, Couteur D, Hesselson D, Triccas J, Neely GG, Gamble JR, Simpson SJ, Saunders BM, Oliver BG, Britton WJ, Wark PA, Nold-Petry CA, Hansbro PM. Animal and translational models of SARS-CoV-2 infection and COVID-19. Mucosal Immunol 2020;13:877-91. [PMID: 32820248 DOI: 10.1038/s41385-020-00340-z] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 30.0] [Reference Citation Analysis]
192 Poppe M, Wittig S, Jurida L, Bartkuhn M, Wilhelm J, Müller H, Beuerlein K, Karl N, Bhuju S, Ziebuhr J, Schmitz ML, Kracht M. The NF-κB-dependent and -independent transcriptome and chromatin landscapes of human coronavirus 229E-infected cells. PLoS Pathog 2017;13:e1006286. [PMID: 28355270 DOI: 10.1371/journal.ppat.1006286] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 8.8] [Reference Citation Analysis]
193 [DOI: 10.1101/2020.02.12.945576] [Cited by in Crossref: 104] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
194 Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020;215:108427. [PMID: 32325252 DOI: 10.1016/j.clim.2020.108427] [Cited by in Crossref: 475] [Cited by in F6Publishing: 397] [Article Influence: 237.5] [Reference Citation Analysis]
195 Rimmelzwaan GF, Fouchier RA, Osterhaus AD. Age distribution of cases caused by different influenza viruses. Lancet Infect Dis 2013;13:646-7. [PMID: 23886322 DOI: 10.1016/S1473-3099(13)70181-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
196 Sunkara H, Dewan SMR. Coronavirus disease-2019: A review on the disease exacerbation via cytokine storm and concurrent management. Int Immunopharmacol 2021;99:108049. [PMID: 34426104 DOI: 10.1016/j.intimp.2021.108049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Albitar O, Ballouze R, Ooi JP, Sheikh Ghadzi SM. Risk factors for mortality among COVID-19 patients. Diabetes Res Clin Pract 2020;166:108293. [PMID: 32623035 DOI: 10.1016/j.diabres.2020.108293] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 17.0] [Reference Citation Analysis]
198 Rockx B, Kuiken T, Herfst S, Bestebroer T, Lamers MM, Oude Munnink BB, de Meulder D, van Amerongen G, van den Brand J, Okba NMA, Schipper D, van Run P, Leijten L, Sikkema R, Verschoor E, Verstrepen B, Bogers W, Langermans J, Drosten C, Fentener van Vlissingen M, Fouchier R, de Swart R, Koopmans M, Haagmans BL. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science 2020;368:1012-5. [PMID: 32303590 DOI: 10.1126/science.abb7314] [Cited by in Crossref: 429] [Cited by in F6Publishing: 441] [Article Influence: 214.5] [Reference Citation Analysis]
199 Zhao J, Zhao J, Perlman S. T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. J Virol 2010;84:9318-25. [PMID: 20610717 DOI: 10.1128/JVI.01049-10] [Cited by in Crossref: 217] [Cited by in F6Publishing: 150] [Article Influence: 18.1] [Reference Citation Analysis]
200 Liu L, Wei Q, Alvarez X, Wang H, Du Y, Zhu H, Jiang H, Zhou J, Lam P, Zhang L, Lackner A, Qin C, Chen Z. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J Virol. 2011;85:4025-4030. [PMID: 21289121 DOI: 10.1128/jvi.02292-10] [Cited by in Crossref: 183] [Cited by in F6Publishing: 123] [Article Influence: 16.6] [Reference Citation Analysis]
201 Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol 2020;85:104502. [PMID: 32798769 DOI: 10.1016/j.meegid.2020.104502] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
202 Mary A, Hénaut L, Macq PY, Badoux L, Cappe A, Porée T, Eckes M, Dupont H, Brazier M. Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b-Literature Review and Personal Preliminary Experience. Front Pharmacol 2020;11:592543. [PMID: 33329000 DOI: 10.3389/fphar.2020.592543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
203 van den Brand JM, Haagmans BL, van Riel D, Osterhaus AD, Kuiken T. The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol. 2014;151:83-112. [PMID: 24581932 DOI: 10.1016/j.jcpa.2014.01.004] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 10.9] [Reference Citation Analysis]
204 Guo Y, Hu K, Li Y, Lu C, Ling K, Cai C, Wang W, Ye D. Targeting TNF-α for COVID-19: Recent Advanced and Controversies. Front Public Health 2022;10:833967. [DOI: 10.3389/fpubh.2022.833967] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
205 Neri P, Pichi F. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights. Int Ophthalmol 2020;40:1057-60. [PMID: 32314322 DOI: 10.1007/s10792-020-01389-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 9.5] [Reference Citation Analysis]
206 de Vries RD, Rockx B, Haagmans BL, Herfst S, Koopmans MP, de Swart RL. Animal models of SARS-CoV-2 transmission. Curr Opin Virol 2021;50:8-16. [PMID: 34256352 DOI: 10.1016/j.coviro.2021.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Agnihothram S, Yount BL Jr, Donaldson EF, Huynh J, Menachery VD, Gralinski LE, Graham RL, Becker MM, Tomar S, Scobey TD, Osswald HL, Whitmore A, Gopal R, Ghosh AK, Mesecar A, Zambon M, Heise M, Denison MR, Baric RS. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. mBio 2014;5:e00047-14. [PMID: 24667706 DOI: 10.1128/mBio.00047-14] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
208 Widjaja G, Turki Jalil A, Sulaiman Rahman H, Kamal Abdelbasset W, Bokov DO, Suksatan W, Ghaebi M, Marofi F, Gholizadeh Navashenaq J, Jadidi-Niaragh F, Ahmadi M. Humoral immune mechanisms involved in protective and pathological immunity during COVID-19. Hum Immunol 2021:S0198-8859(21)00174-9. [PMID: 34229864 DOI: 10.1016/j.humimm.2021.06.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
209 Gao Y, Wang C, Kang K, Peng Y, Luo Y, Liu H, Yang W, Zhao M, Yu K. Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19. Viral Immunol 2021;34:336-41. [PMID: 33202195 DOI: 10.1089/vim.2020.0243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
210 Su L, Tu Y, Kong DP, Chen DG, Zhang CX, Zhang WN, Zhuang CL, Wang ZB. Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents. Biomed Pharmacother 2020;131:110643. [PMID: 32846329 DOI: 10.1016/j.biopha.2020.110643] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
211 Basile MS, Cavalli E, McCubrey J, Hernández-Bello J, Muñoz-Valle JF, Fagone P, Nicoletti F. The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19. Drug Discov Today 2021:S1359-6446(21)00480-3. [PMID: 34763066 DOI: 10.1016/j.drudis.2021.11.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Rodrigues PB, Dos Santos Pereira Gomes AB, Genaro LM, Pascoal LB, de Souza APD, Leal RF, Vinolo MAR. Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known? Adv Exp Med Biol 2021;1327:93-106. [PMID: 34279831 DOI: 10.1007/978-3-030-71697-4_7] [Reference Citation Analysis]
213 Zhou J, Huang L, Chen J, Yuan X, Shen Q, Dong S, Cheng B, Guo T. Clinical features predicting mortality risk in older patients with COVID-19. Current Medical Research and Opinion 2020;36:1753-9. [DOI: 10.1080/03007995.2020.1825365] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
214 Nolte MA, van der Meer JW. Inflammatory responses to infection: the Dutch contribution. Immunol Lett 2014;162:113-20. [PMID: 25455597 DOI: 10.1016/j.imlet.2014.10.007] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
215 Wieczfinska J, Kleniewska P, Pawliczak R, Kouretas D. Oxidative Stress-Related Mechanisms in SARS-CoV-2 Infections. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/5589089] [Reference Citation Analysis]
216 Batu ED, Özen S. Implications of COVID-19 in pediatric rheumatology. Rheumatol Int 2020;40:1193-213. [PMID: 32500409 DOI: 10.1007/s00296-020-04612-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
217 Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct Target Ther 2020;5:84. [PMID: 32467561 DOI: 10.1038/s41392-020-0191-1] [Cited by in Crossref: 206] [Cited by in F6Publishing: 208] [Article Influence: 103.0] [Reference Citation Analysis]
218 Hendrickson CM, Matthay MA. Viral Pathogens and Acute Lung Injury: Investigations Inspired by the SARS Epidemic and the 2009 H1N1 Influenza Pandemic. Semin Respir Crit Care Med. 2013;34:475-486. [PMID: 23934716 DOI: 10.1055/s-0033-1351122] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
219 O'Donnell L, Hill EC, Anderson ASA, Edgar HJH. Cribra orbitalia and porotic hyperostosis are associated with respiratory infections in a contemporary mortality sample from New Mexico. Am J Phys Anthropol 2020;173:721-33. [PMID: 32869279 DOI: 10.1002/ajpa.24131] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
220 Fukuyama S, Iwatsuki-Horimoto K, Kiso M, Nakajima N, Gregg RW, Katsura H, Tomita Y, Maemura T, da Silva Lopes TJ, Watanabe T, Shoemaker JE, Hasegawa H, Yamayoshi S, Kawaoka Y. Pathogenesis of Influenza A(H7N9) Virus in Aged Nonhuman Primates. J Infect Dis 2020;222:1155-64. [PMID: 32433769 DOI: 10.1093/infdis/jiaa267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
221 Channappanavar R, Perlman S. Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity. J Clin Invest 2020;130:6204-13. [PMID: 33085654 DOI: 10.1172/JCI144115] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
222 Yen Y, Chan S, Chen C, Deng C. Predictors for Early and Late Death in Adult Patients with COVID-19: A Cohort Study. IJERPH 2022;19:3357. [DOI: 10.3390/ijerph19063357] [Reference Citation Analysis]
223 Anwar MM, Sah R, Shrestha S, Ozaki A, Roy N, Fathah Z, Rodriguez-Morales AJ. Disengaging the COVID-19 Clutch as a Discerning Eye Over the Inflammatory Circuit During SARS-CoV-2 Infection. Inflammation 2022. [PMID: 35639261 DOI: 10.1007/s10753-022-01674-5] [Reference Citation Analysis]
224 Hu J, Han Z, Heidari AA, Shou Y, Ye H, Wang L, Huang X, Chen H, Chen Y, Wu P. Detection of COVID-19 severity using blood gas analysis parameters and Harris hawks optimized extreme learning machine. Computers in Biology and Medicine 2021. [DOI: 10.1016/j.compbiomed.2021.105166] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
225 Barksdale C, Kipper FC, Tripathy S, Subbian S, Serhan CN, Panigrahy D. COVID-19 and cancer: start the resolution! Cancer Metastasis Rev 2022. [PMID: 35190921 DOI: 10.1007/s10555-021-10017-z] [Reference Citation Analysis]
226 Blagosklonny MV. From causes of aging to death from COVID-19. Aging (Albany NY) 2020;12:10004-21. [PMID: 32534452 DOI: 10.18632/aging.103493] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
227 Tammam SN, El Safy S, Ramadan S, Arjune S, Krakor E, Mathur S. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2. J Control Release 2021;337:258-84. [PMID: 34293319 DOI: 10.1016/j.jconrel.2021.07.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
228 Totura AL, Bavari S. Broad-spectrum coronavirus antiviral drug discovery. Expert Opin Drug Discov 2019;14:397-412. [PMID: 30849247 DOI: 10.1080/17460441.2019.1581171] [Cited by in Crossref: 90] [Cited by in F6Publishing: 77] [Article Influence: 30.0] [Reference Citation Analysis]
229 Patra S, Kerry RG, Maurya GK, Panigrahi B, Kumari S, Rout JR. Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition. Front Microbiol 2020;11:2098. [PMID: 33193115 DOI: 10.3389/fmicb.2020.02098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
230 Dioguardi M, Cazzolla AP, Arena C, Sovereto D, Caloro GA, Dioguardi A, Crincoli V, Laino L, Troiano G, Lo Muzio L. Innate Immunity in Children and the Role of ACE2 Expression in SARS-CoV-2 Infection. Pediatr Rep 2021;13:363-82. [PMID: 34287338 DOI: 10.3390/pediatric13030045] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
231 Hammock BD, Wang W, Gilligan MM, Panigrahy D. Eicosanoids: The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)? Am J Pathol 2020;190:1782-8. [PMID: 32650004 DOI: 10.1016/j.ajpath.2020.06.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
232 Lohner L, Fröb D, Edler C, Schröder AS, Dietz E, Ondruschka B. [SARS-CoV-2-associated deaths in adult persons up to 50 years of age]. Rechtsmedizin (Berl) 2021;:1-9. [PMID: 33867689 DOI: 10.1007/s00194-021-00483-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
233 Chan MC, Kuok DI, Leung CY, Hui KP, Valkenburg SA, Lau EH, Nicholls JM, Fang X, Guan Y, Lee JW, Chan RW, Webster RG, Matthay MA, Peiris JS. Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo. Proc Natl Acad Sci U S A. 2016;113:3621-3626. [PMID: 26976597 DOI: 10.1073/pnas.1601911113] [Cited by in Crossref: 106] [Cited by in F6Publishing: 106] [Article Influence: 17.7] [Reference Citation Analysis]
234 Cen Y, Chen X, Shen Y, Zhang XH, Lei Y, Xu C, Jiang WR, Xu HT, Chen Y, Zhu J, Zhang LL, Liu YH. Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study. Clin Microbiol Infect 2020;26:1242-7. [PMID: 32526275 DOI: 10.1016/j.cmi.2020.05.041] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 24.5] [Reference Citation Analysis]
235 Mohammed M, Muhammad S, Mohammed FZ, Mustapha S, Sha'aban A, Sani NY, Ahmad MH, Bala AA, Ungogo MA, Alotaibi NM, Zainal H. Risk Factors Associated with Mortality Among Patients with Novel Coronavirus Disease (COVID-19) in Africa. J Racial Ethn Health Disparities 2020. [PMID: 33051749 DOI: 10.1007/s40615-020-00888-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Siracusano G, Pastori C, Lopalco L. Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art. Front Immunol 2020;11:1049. [PMID: 32574261 DOI: 10.3389/fimmu.2020.01049] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 22.0] [Reference Citation Analysis]
237 Goodnow CC. COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints. Immunol Cell Biol 2021;99:177-91. [PMID: 33113212 DOI: 10.1111/imcb.12419] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
238 Griffin BD, Warner BM, Chan M, Valcourt E, Tailor N, Banadyga L, Leung A, He S, Boese AS, Audet J, Cao W, Moffat E, Garnett L, Tierney K, Tran KN, Albietz A, Manguiat K, Soule G, Bello A, Vendramelli R, Lin J, Deschambault Y, Zhu W, Wood H, Mubareka S, Safronetz D, Strong JE, Embury-Hyatt C, Kobasa D. Host parameters and mode of infection influence outcome in SARS-CoV-2-infected hamsters. iScience 2021;24:103530. [PMID: 34870132 DOI: 10.1016/j.isci.2021.103530] [Reference Citation Analysis]
239 Mahdavi M, Choubdar H, Zabeh E, Rieder M, Safavi-Naeini S, Jobbagy Z, Ghorbani A, Abedini A, Kiani A, Khanlarzadeh V, Lashgari R, Kamrani E. A machine learning based exploration of COVID-19 mortality risk. PLoS One 2021;16:e0252384. [PMID: 34214101 DOI: 10.1371/journal.pone.0252384] [Reference Citation Analysis]
240 Liao MT, Wu CC, Wu SV, Lee MC, Hu WC, Tsai KW, Yang CH, Lu CL, Chiu SK, Lu KC. Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients. Antioxidants (Basel) 2021;10:1440. [PMID: 34573071 DOI: 10.3390/antiox10091440] [Reference Citation Analysis]